Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Postgraduate Medicine|February 5, 2011
Focus on incretin-based therapies: targeting the core defects of type 2 diabetesPaul S JellingerClinical Cornerstone|December 25, 2007
Metabolic consequences of hyperglycemia and insulin resistancePaul S JellingerDiabetes Spectrum : a Publication of the American Diabetes Association|August 25, 2018
American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice GuidelinesPaul S JellingerJournal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Overcoming obstacles in risk factor management in type 2 diabetes mellitusYehuda Handelsman, Paul S JellingerPostgraduate Medicine|June 29, 2010
The potential role of colesevelam in the management of prediabetes and type 2 diabetes mellitusPhilip Levy, Paul S JellingerPostgraduate Medicine|May 24, 2016
Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profileStanley S Schwartz, Paul S Jellinger, Mary E HermanEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 28, 2009
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic controlHelena W Rodbard, Paul S Jellinger, Jaime A Davidson, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 25, 2017
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASEPaul S Jellinger, Yehuda Handelsman, Paul D Rosenblit, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive SummaryYehuda Handelsman, Paul S Jellinger, Chris K Guerin, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 4, 2017
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.comPaul S Jellinger, Yehuda Handelsman, Paul D Rosenblit, et al.Pageof 2